Oakhurst

Oakhurst Therapeutics is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of high-value therapeutic products for patients with unmet medical needs. The company primarily targets late-stage or approved assets in specialty areas such as neurology and pain management, aiming to optimize their clinical and commercial potential. By leveraging a lean operational model and strategic partnerships, Oakhurst focuses on delivering cost-effective and innovative treatment options. The company's business strategy involves identifying undervalued pharmaceutical assets and revitalizing them through targeted investment and commercial expertise.